跳至主要内容
临床试验/IRCT20200413047063N3
IRCT20200413047063N3招募中1 期

Safety of injection of placental mesenchymal stem cell derived exosomes for Treatment of resistant perianal fistula in Crohn's patients

Omid cell and tissue Company0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • Patient with Crohn or other IBD disease, resistance to a 6 month period of treatment with anti TNF, without any success
  • Patient with Crohn or other IBD disease, resistance to a 6 month period of treatment with infliximab, without any success
  • Patient with Crohn or other IBD disease, resistance to a 6 month period of treatment with infliximab and anti TNF, without any success
  • Patient with Crohn or other IBD disease, resistance to a 6 month period of drug therapy and surgery, without any success

排除标准

  • Patients with immunodeficiency disorders/disease
  • Patients with history of malignancy
  • Patient dissatisfaction
  • Patients in need of surgery
  • Severe co-morbidities (e.g., renal failure, liver failure, etc.)
  • Cerebral Damage

研究者

发起方
Omid cell and tissue Company

相似试验